A citation-based method for searching scientific literature

Ajay Varanasi, Natalie Bellini, Deepti Rawal, Mehul Vora, Antoine Makdissi, Sandeep Dhindsa, Ajay Chaudhuri, Paresh Dandona. Eur J Endocrinol 2011
Times Cited: 97



Daniel J Drucker, John B Buse, Kristin Taylor, David M Kendall, Michael Trautmann, Dongliang Zhuang, Lisa Porter. Lancet 2008
Times Cited: 708




List of shared articles



Times cited

Current issues in GLP-1 receptor agonist therapy for type 2 diabetes.
Zachary T Bloomgarden, Lawrence Blonde, Alan J Garber, Carol H Wysham. Endocr Pract 2012
7


Beyond glycaemic control: A cross-over, double-blinded, 24-week intervention with liraglutide in type 1 diabetes.
Marie-Christine Dubé, Martin D'Amours, S John Weisnagel. Diabetes Obes Metab 2018
12


Efficacy and safety of exenatide once weekly: an overview of the DURATION trials.
Christophe Em De Block, Luc F Van Gaal. Expert Rev Endocrinol Metab 2012
2


How to fight obesity with antidiabetic drugs: targeting gut or kidney?
M Baretić, R Troskot. Minerva Endocrinol 2015
4

Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy.
Andrea N Traina, Melinda E Lull, Adrian C Hui, Toni M Zahorian, Jane Lyons-Patterson. Can J Diabetes 2014
32


GLP-1 agonists in type 1 diabetes.
Jeremy Pettus, Irl Hirsch, Steven Edelman. Clin Immunol 2013
28


Recent advances in incretin-based therapies.
David Russell-Jones, Stephen Gough. Clin Endocrinol (Oxf) 2012
49